Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PGFW | ISIN: CNE100003F01 | Ticker-Symbol: CJH
Tradegate
01.04.25
07:32 Uhr
4,080 Euro
+0,060
+1,49 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
CANSINO BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
CANSINO BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,0204,26010:59
4,0204,24010:57

Aktuelle News zur CANSINO BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.03.CanSino Biologics Inc: Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong166HONG KONG, Mar 25, 2025 - (ACN Newswire) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant...
► Artikel lesen
25.03.CANSINOBIO (06185): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024-
12.03.CANSINOBIO (06185): NOTICE OF BOARD MEETING4
27.02.CANSINOBIO (06185): INSIDE INFORMATION - UPDATES ON 2024 PRELIMINARY ANNUAL RESULTS4
24.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - DTCP-HIB-MCV4 COMBINED VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA14
17.02.CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai305DUBAI, UAE, Feb. 17, 2025 /PRNewswire/ -- CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in...
► Artikel lesen
07.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR DTCP INFANT4
06.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TETANUS VACCINE6
CANSINO BIOLOGICS Aktie jetzt für 0€ handeln
17.01.CANSINOBIO (06185): INSIDE INFORMATION - RESULTS FORECAST FOR THE YEAR 20249
30.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - MENHYCIA OBTAINS DRUG REGISTRATION CERTIFICATE IN INDONESIA1
20.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I/II CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE I CLINICAL TRIAL ...-
20.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II/III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE II CLINICAL ...4
16.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR DTCP INFANT1
13.12.24CANSINOBIO (06185): INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT1
26.11.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL DRUG APPLICATION FOR MENHYCIA10
25.11.24CANSINOBIO (06185): CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR2
15.11.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR HAEMOPHILUS INFLUENZAE ...2
29.10.24CANSINOBIO (06185): THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 20248
16.10.24CANSINOBIO (06185): NOTICE OF BOARD MEETING5
09.10.24CanSino Biologics Inc: CanSino Receives Another Strong Boost347- VLP-Polio Expected to Accelerate Development and Fill the Gap.HONG KONG, Oct 9, 2024 - (ACN Newswire) - CanSino Biologics Inc. ("CanSinoBIO" or "the Company") has announced a milestone in its fight...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1